Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.
Anupam Rasayan India announces commercialization of ETFA production via a proprietary continuous flow chemistry platform, making it the first globally to do so. The market potential for ETFA is $500-600 million, crucial for fluorinated compounds in pharmaceuticals and life sciences.
<iframe src="https://hindustansphere.com/embed/cluster/eead5e01e75c0b33adfd75b56a21931f4b55dcaf" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Multibagger Anupam Rasayan stock to be in focus on Friday on ETFA manufacturing milestone"></iframe>
